These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 430202)

  • 1. A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.
    Fogelman I; Citrin DL; McKillop JH; Turner JG; Bessent RG; Greig WR
    J Nucl Med; 1979 Feb; 20(2):98-101. PubMed ID: 430202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
    Rudd TG; Allen DR; Smith FD
    J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy: concise communication.
    Silberstein EB; Maxon HR; Alexander GW; Rauf C; Bahr GK
    J Nucl Med; 1978 Feb; 19(2):161-3. PubMed ID: 203665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
    Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
    J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical comparison of Tc-99m HEDP and Tc-99m MDP.
    Coupal JJ; Kim EE
    J Nucl Med; 1979 Aug; 20(8):896-7. PubMed ID: 120424
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
    Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
    Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate in acute myocardial infarction: concise communication.
    Kelly RJ; Chilton H; Hackshaw BT; Ball JD; Watson NE; Kahl FR; Cowan FJ
    J Nucl Med; 1979 May; 20(5):402-6. PubMed ID: 232147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic detection of osteomyelitis with Tc-99m MDP and Ga-67 citrate: concise communication.
    Graham GD; Lundy MM; Frederick RJ; Hartshorne MF; Berger DE
    J Nucl Med; 1983 Nov; 24(11):1019-22. PubMed ID: 6226766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of radiopharmaceuticals for diagnosis and therapy of metastatic bone cancer].
    Ogawa K
    Yakugaku Zasshi; 2012; 132(10):1151-7. PubMed ID: 23037700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
    Rudd TG; Allen DR; Hartnett DE
    J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
    Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
    J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
    Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Wang SJ; Ting G
    Nucl Med Biol; 1999 Nov; 26(8):973-6. PubMed ID: 10708313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.